Multiple electrolyte abnormalities after pamidronate administration.
Nephron
; 79(3): 337-9, 1998.
Article
en En
| MEDLINE
| ID: mdl-9678436
ABSTRACT
Pamidronate constitutes a major advance in the treatment of tumor-associated hypercalcemia. However, transient electrolyte abnormalities have been reported after pamidronate administration. We describe here a patient with multiple myeloma and severe hypercalcemia who developed transient but significant electrolyte disturbances (mainly hypophosphatemia and hypomagnesemia) after a single dose of 90 mg of pamidronate, focusing on the underlying pathophysiological mechanisms.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hipofosfatemia
/
Difosfonatos
/
Electrólitos
/
Magnesio
/
Antineoplásicos
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Nephron
Año:
1998
Tipo del documento:
Article
País de afiliación:
Grecia
Pais de publicación:
CH
/
SUIZA
/
SUÍÇA
/
SWITZERLAND